Pfizer (PFE) Tops Q4 EPS by 8c, Beats on Revenue; Offers FY26 Guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $24.72 -1.44%
Revenue Growth %: -1.8%
Financial Fact:
Provision for taxes on income: 284M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Revenue Growth %: -1.8%
Financial Fact:
Provision for taxes on income: 284M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q4 EPS of $0.66, $0.08 better than the analyst estimate of $0.58. Revenue for the quarter came in at $17.58 billion versus the consensus estimate of $16.91 billion.
GUIDANCE:
Pfizer sees FY2026 EPS of $2.80-$3.00, versus the consensus of $2.97. Pfizer sees FY2026 revenue of $59.5-62.5 billion, versus the consensus of $61 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
